The role of GTSE1 in drug resistance is shown in gastric cancer cells [24], osteosarcoma [25], breast cancer [23], clear cell renal cell carcinoma [19], and non-small-cell lung cancer [26]. Here, GTSE1 is linked to breast carcinoma.